Comparez les meilleurs médecins Immunothérapie pour le cancer de la prostate et les prix en Turquie. Trouvez votre meilleure correspondance ici.

Choisissez le pays avec les meilleurs prix pour les services médicaux

Comparez les prix de Immunothérapie pour le cancer de la prostate dans les principaux pays

Touchez un pays pour voir les meilleurs médecins et prix

Israel

Ukraine

Turkey

Poland

Czech Republic

Austria

$2,200 - $3,600

$9,000 - $17,000

$12,000 - $25,000

$18,000 - $26,000

$30,000 - $50,000

$30,000 - $60,000

$16,000

$32,000

$48,000

Obtenez gratuitement des plans de traitement personnalisés et choisissez la meilleure option. Sans engagement · Aucun paiement pour nos services

Muhammed Gomec

17 années d'expérience
Lieu : Turquie, Sivas
Clinique :
5.0
Medicana Sivas Hospital

Visite du médecin

Prix sur demande

Alandag Celal

17 années d'expérience
Lieu : Turquie, Sivas
Clinique :
5.0
Medicana Sivas Hospital

Visite du médecin

Prix sur demande

Bookimed Insights : Meilleurs spécialistes d'immunothérapie pour le cancer de la prostate en Turquie (2026)

Bookimed a coordonné 54048 demandes pour Immunothérapie pour le cancer de la prostate en Turquie, en collaboration avec 2 spécialistes. Les médecins de ce tableau se distinguent régulièrement par leurs qualifications et leur expertise à répondre aux besoins spécifiques des patients. Toutes les informations proviennent de cas réels de patients et d'offres de traitement créées par nos cliniques partenaires.

Classement	Médecin	expérience	Bon choix pour	Ce qui les distingue	Clinique et emplacement	Consultation

FAQ

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

What qualifications should I look for in top immunotherapy doctors in Turkey who treat prostate cancer?

Top immunotherapy doctors in Turkey are medical oncologists with academic titles like Professor or Associate Professor. They hold European Society for Medical Oncology (ESMO) certification and specialize in molecular tumor biology. These experts practice in JCI-accredited centers that collaborate with major international medical institutions.

Board certification: Specialists hold Turkish or European medical oncology certifications for systemic treatments.
Subspecialty focus: Leading doctors focus on urogenital cancers and advanced tumor immunology research.
International training: Many experts completed fellowships at institutions like Cleveland Clinic or MD Anderson.
Academic rank: Titles like Professor denote extensive clinical experience and major research contributions.

Bookimed Expert Insight: Data shows that top-tier Turkish oncologists often integrate molecular diagnostics into personalized care. For instance, Dr. Cemil Bilir trained at the Cleveland Clinic in nanomedicine, while Dr. Yesim Yildirim has published 80+ papers. This research-heavy background is crucial for determining if a patient is eligible for specific immunotherapy drugs based on genetic markers.

Patient Consensus: Patients note it is important to choose doctors who explain why immunotherapy fits their specific cancer subtype. They often feel more confident with specialists who work in multidisciplinary teams alongside urologists. Many suggest asking how the doctor manages potential immune-related side effects during treatment.

Which doctors in Turkey have the most experience with advanced forms of immunotherapy like CAR-T or cell therapy for prostate cancer?

Turkish medical oncologists provide access to advanced prostate cancer protocols using checkpoint inhibitors and targeted therapies. While CAR-T remains experimental for solid tumors, specialists at Anadolu Medical Center and Hisar Hospital integrate international expertise from MD Anderson and Johns Hopkins Medicine to manage complex cases.

International training: Dr. Mustafa Solak at Hisar Hospital completed training at MD Anderson Cancer Center.
Academic expertise: Prof. Yesim Yildirim at Anadolu Medical Center has over 80 international cancer publications.
Multidisciplinary approach: Dr. Bulent Karagoz specializes in tumor immunology and biology for targeted treatment.
Urogenital specialization: Dr. Sinan Karaaslan focuses specifically on immunotherapy for urogenital system cancers.

Bookimed Expert Insight: Data shows that premier Turkish centers often serve as extension hubs for American standards. For example, Anadolu Medical Center's affiliation with Johns Hopkins Medicine allows doctors to provide molecular profiling. This ensures patients receive immunotherapy tracks aligned with US clinical protocols. Expert consultations are available starting from $100 with Dr. Mustafa Solak and $215 with specialists at Anadolu.

Patient Consensus: Patients note it is important to clarify the specific type of immunotherapy before traveling. Many say they had to distinguish between standard drug treatments and experimental clinical trials. Those who traveled emphasize that clear communication about cell therapy types helped manage their expectations.

How can I verify the actual experience level of a specific doctor with prostate-cancer immunotherapy before choosing them?

Verifying a doctor's expertise in prostate cancer immunotherapy requires analyzing their academic research history and clinical certifications. In Turkey, top oncologists combine intensive clinical practice with roles in international trials. You should prioritize doctors with European Society for Medical Oncology certification and active records in peer-reviewed research.

Academic publication history: High-level experts like Dr. Bulent Karagoz have authored over 40 cancer research publications.
European board certification: Qualified specialists often hold ESMO Board Certification to demonstrate mastery in oncology.
Clinical trial involvement: Leading doctors like Dr. Nail Paksoy serve as subinvestigators in international clinical trials.
Specialized fellowship training: Top practitioners often complete advanced immunotherapy training at international centers in London or Israel.

Bookimed Expert Insight: For complex prostate cases, the most experienced doctors in Turkey often hold joint appointments as university professors. Dr. Yesim Yildirim and Dr. Bulent Karagoz both balance clinical work with academic leadership. This ensures they are using the latest immunotherapy protocols long before they become standard practice. Patients may also book consultations with these specialists starting from $215.

Patient Consensus: Patients note it's important to ask how many immunotherapy cases the doctor handled in the last year. They recommend checking if the surgeon participates in multidisciplinary boards rather than making solo treatment decisions. Many were surprised by the depth of detail doctors provided about specific biomarkers during the initial consultation.

Can Turkish doctors provide personalised prostate-cancer immunotherapy based on biomarkers?

Turkish oncologists provide personalised immunotherapy for prostate cancer using biomarker profiling and genetic sequencing. Specialists like Dr. Bulent Karagoz and Dr. Yesim Yildirim at Anadolu Medical Center design precision protocols. These treatments align with international standards set by the European Society for Medical Oncology (ESMO).

Molecular profiling: Clinics screen for biomarkers like MSI-H and dMMR to determine eligibility.
Advanced diagnostics: Specialists use liquid biopsies and PSMA PET-CT for precise tumor genetic updates.
Specialised training: Many doctors hold fellowships from MD Anderson Cancer Center or Oxford University.
Clinic standards: Top facilities hold JCI accreditation and partnerships with Johns Hopkins Medicine.

Bookimed Expert Insight: While immunotherapy is often linked to academic centers, Turkish experts bridge the gap between research and practice. Dr. Nail Paksoy and Dr. Cemil Bilir integrate nanomedicine and clinical trial data directly into patient care. This ensures that even rare biomarker-positive cases receive protocols often found only at major global research institutes.

Patient Consensus: Patients note that biomarker testing is the essential first step before starting any therapy. They emphasize the importance of confirming genetic markers like MSI-high to ensure a drug will work. Many felt more confident after having their genomic reports reviewed by a multidisciplinary oncology board.

Les meilleurs doctors à Sivas pour votre Immunothérapie pour le cancer de la prostate - TOP 2 des médecins

Obtenez des devis de 3 meilleurs spécialistes Immunothérapie pour le cancer de la prostate en Turquie